Annovis Bio (ANVS) Accumulated Expenses (2019 - 2026)
Annovis Bio's Accumulated Expenses was $3.03 million in Q2 2026, up 65.6% from $1.83 million a year earlier but down 59.7% from the prior quarter.
Powered by 
Analysis
Annovis Bio (ANVS) Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Annovis Bio came in at $1.04 million, down 33.7% from FY2024.
- Accumulated Expenses has now declined for three consecutive years, though with a five-year compound annual growth rate of 34.6% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $1.58 million in FY2024 (-47.3%), $2.99 million in FY2023 (-20.1%), $3.74 million in FY2022 (+356.6%) and $818,440 in FY2021 (+246.0%).
- Quarterly Accumulated Expenses has moved between $397,544 (Q2 2022) and $7.51 million (Q1 2026) over five years.
- Compared with a year earlier, Accumulated Expenses was higher in five of the last eight quarters, with growth averaging 97.1%.
- The best year-over-year quarter for Accumulated Expenses over five years was Q1 2026 (growth of 562.6%); the worst was Q2 2022 (a decline of 48.3%).
- Per Business Quant data, ANVS's Accumulated Expenses in the three quarters before Q2 2026 was $7.51 million (Q1 2026), $1.04 million (Q4 2025) and $1.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Annovis Bio | 54.11 Mn | 54.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.03 Mn |
| Mar 31, 2026 | 7.51 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 662,682.00 |
| Mar 31, 2024 | 763,183.00 |
| Dec 31, 2023 | 2.99 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 900,972.00 |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 3.74 Mn |
| Sep 30, 2022 | 680,830.00 |
| Jun 30, 2022 | 397,544.00 |
| Mar 31, 2022 | 468,125.00 |
| Dec 31, 2021 | 818,440.00 |
| Sep 30, 2021 | 830,859.00 |
API Access
Annovis Bio Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ANVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ANVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ANVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();